Viewing StudyNCT00519090



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00519090
Status: TERMINATED
Last Update Posted: 2011-11-06
First Post: 2007-08-17

Brief Title: Nilotinib vs Imatinib in Adult Patients With Philadelphia Ph Chronic Myelogenous Leukemia in Chronic Phase CML-CP
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Myelogenous Leukemia
Keywords:
Name View
chronic myelogenous leukemia in chronic phase CML-CP View
leukemia View
bone marrow View
leukemia symptoms View
cml View
complete blood count View
lymphocyte View
blood cancer View
leukocytes View
chronic leukemia View
bone marrow biopsy View
leukemia research View
leukemia cells View
bone marrow disease View
chronic myeloid leukemia View
blood cancer symptoms View
white blood cell diseases View
chronic myelogenous leukemia View
leukemia treatment View
leukemia facts View
leucemia View
facts about leukemia View
myelogenous leukemia View
newly diagnosed CML View
suboptimal response View
Philadelphia chromosome positive Ph View